{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:03:48Z","timestamp":1790334228847,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16H06277"],"award-info":[{"award-number":["16H06277"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H04923 (CoBiA)"],"award-info":[{"award-number":["22H04923 (CoBiA)"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K06706"],"award-info":[{"award-number":["22K06706"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.dmd.2026.100366","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:21:45Z","timestamp":1784071305000},"page":"100366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discovery of novel plasma biomarkers for OATP1B1 activity using nontargeted metabolomics"],"prefix":"10.1016","volume":"54","author":[{"given":"Jun","family":"Negami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7092-4618","authenticated-orcid":false,"given":"Yosuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhide","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koudai","family":"Iino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakura","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuki","family":"Kamio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuko","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6922-4835","authenticated-orcid":false,"given":"Yasuyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nakatochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5638-3504","authenticated-orcid":false,"given":"Yukihide","family":"Momozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2026-2142","authenticated-orcid":false,"given":"Takahiro","family":"Sumimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Tatsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmd.2026.100366_bib1","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1476-5381.2009.00430.x","article-title":"Impact of OATP transporters on pharmacokinetics","volume":"158","author":"Kalliokoski","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.dmd.2026.100366_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/pr.110.002857","article-title":"Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake","volume":"63","author":"Niemi","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.dmd.2026.100366_bib3","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.dmd.2026.100366_bib4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/17425255.2022.2113380","article-title":"The role of OATP1B1 and OATP1B3 transporter polymorphisms in drug disposition and response to anticancer drugs: a review of the recent literature","volume":"18","author":"Anabtawi","year":"2022","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.dmd.2026.100366_bib5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1124\/dmd.108.023630","article-title":"Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6","volume":"37","author":"Le Vee","year":"2009","journal-title":"Drug Metab. Dispos"},{"key":"10.1016\/j.dmd.2026.100366_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13731","article-title":"Relationship of plasma 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid concentration with OATP1B activity in patients with chronic kidney disease","volume":"17","author":"Ono","year":"2024","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.dmd.2026.100366_bib7","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/cpt.2375","article-title":"Factors influencing plasma coproporphyrin-I concentration as biomarker of OATP1B activity in patients with rheumatoid arthritis","volume":"110","author":"Ono","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmd.2026.100366_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00228-021-03233-7","article-title":"Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case-control study","volume":"78","author":"Mercep","year":"2022","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.dmd.2026.100366_bib9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/cpt.2053","article-title":"Identification of glycochenodeoxycholate 3-O-glucuronide and glycodeoxycholate 3-O-glucuronide as highly sensitive and specific OATP1B1 biomarkers","volume":"109","author":"Neuvonen","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmd.2026.100366_bib10","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/cpt.2674","article-title":"Genomewide association study of simvastatin pharmacokinetics","volume":"112","author":"Mykkanen","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmd.2026.100366_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2217\/14622416.9.1.19","article-title":"Global analysis of genetic variation in SLCO1B1","volume":"9","author":"Pasanen","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.dmd.2026.100366_bib12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/cts.12889","article-title":"Substantially increased plasma coproporphyrin-I concentrations associated with OATP1B1\u221715 allele in Japanese general population","volume":"14","author":"Suzuki","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.dmd.2026.100366_bib13","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/17425255.2020.1801634","article-title":"An updated review of pharmacokinetic drug interactions and pharmacogenetics of statins","volume":"16","author":"Hirota","year":"2020","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.dmd.2026.100366_bib14","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3390\/pharmaceutics16080992","article-title":"Innovative approaches to optimize clinical transporter drug-drug interaction studies","volume":"16","author":"Paglialunga","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.dmd.2026.100366_bib15","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1124\/dmd.123.001285","article-title":"Progress in the quantitative assessment of transporter-mediated drug-drug interactions using endogenous substrates in clinical studies","volume":"51","author":"Mochizuki","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2026.100366_bib16","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/cpt.1216","article-title":"Clinical probes and endogenous biomarkers as substrates for transporter drug-drug interaction evaluation: perspectives from the international transporter consortium","volume":"104","author":"Chu","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmd.2026.100366_bib17","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1124\/dmd.117.075531","article-title":"Comparative evaluation of plasma bile acids, dehydroepiandrosterone sulfate, hexadecanedioate, and tetradecanedioate with coproporphyrins I and III as markers of OATP inhibition in healthy subjects","volume":"45","author":"Shen","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2026.100366_bib18","doi-asserted-by":"crossref","first-page":"47135","DOI":"10.1021\/acsomega.4c07566","article-title":"Ultra-sensitive quantification of coproporphyrin-I and -III in human plasma using ultra-performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry","volume":"9","author":"Negami","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.dmd.2026.100366_bib19","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/cpt.2429","article-title":"Performance of plasma coproporphyrin I and III as OATP1B1 biomarkers in humans","volume":"110","author":"Neuvonen","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmd.2026.100366_bib20","article-title":"Metabolic profiling identified a novel biomarker panel for metabolic syndrome-positive hepatocellular cancer","volume":"12","author":"Cao","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.dmd.2026.100366_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cmet.2016.09.018","article-title":"Metabolomics and metabolic diseases: Where do we stand?","volume":"25","author":"Newgard","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.dmd.2026.100366_bib22","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/cpt.434","article-title":"Metabolomic and genome-wide association studies reveal potential endogenous biomarkers for OATP1B1","volume":"100","author":"Yee","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmd.2026.100366_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13773","article-title":"Non-targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function","volume":"17","author":"Hamalainen","year":"2024","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.dmd.2026.100366_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00726-023-03363-5","article-title":"Identification and characterization of endogenous biomarkers for hepatic vectorial transport (OATP1B3-P-gp) function using metabolomics with serum pharmacology","volume":"56","author":"Jin","year":"2024","journal-title":"Amino Acids"},{"key":"10.1016\/j.dmd.2026.100366_bib25","first-page":"317","article-title":"The Japan Multi-Institutional Collaborative Cohort Study (J-MICC Study) to detect gene-environment interactions for cancer","volume":"8","author":"Hamajima","year":"2007","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.dmd.2026.100366_bib26","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2188\/jea.JE20200147","article-title":"Study profile of the Japan Multi-institutional Collaborative Cohort (J-MICC) Study","volume":"31","author":"Takeuchi","year":"2021","journal-title":"J Epidemiol"},{"key":"10.1016\/j.dmd.2026.100366_bib27","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.dmd.2026.100366_bib28","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.5551\/jat.41517","article-title":"Genetic variants of RAMP2 and CLR are associated with stroke","volume":"24","author":"Koyama","year":"2017","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.dmd.2026.100366_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13742-015-0047-8","article-title":"Second-generation PLINK: rising to the challenge of larger and richer datasets","volume":"4","author":"Chang","year":"2015","journal-title":"Gigascience"},{"key":"10.1016\/j.dmd.2026.100366_bib30","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/ng1847","article-title":"Principal components analysis corrects for stratification in genome-wide association studies","volume":"38","author":"Price","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.dmd.2026.100366_bib31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.dmd.2026.100366_bib32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nmeth.1785","article-title":"A linear complexity phasing method for thousands of genomes","volume":"9","author":"Delaneau","year":"2011","journal-title":"Nat Methods"},{"key":"10.1016\/j.dmd.2026.100366_bib33","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ng.3656","article-title":"Next-generation genotype imputation service and methods","volume":"48","author":"Das","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.dmd.2026.100366_bib34","article-title":"Metabolic profiling on the analysis of different parts of Schisandra chinensis based on UPLC-QTOF-MS with comparative bioactivity assays","volume":"13","author":"Liu","year":"2022","journal-title":"Front Plant Sci"},{"key":"10.1016\/j.dmd.2026.100366_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2023.342128","article-title":"Molecular formula assignment of dissolved organic matter by ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry using two non-targeted data processing approaches: a case study from recirculating aquaculture systems","volume":"1288","author":"Aguilar-Alarcon","year":"2024","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.dmd.2026.100366_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.aca.2018.11.009","article-title":"Profiling and comparison of toxicant metabolites in hair and urine using a mass spectrometry-based metabolomic data processing method","volume":"1052","author":"Shih","year":"2019","journal-title":"Anal Chim Acta"},{"key":"10.1016\/j.dmd.2026.100366_bib37","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3390\/molecules29092155","article-title":"Untargeted metabolomics based on ultra-high-performance liquid chromatography coupled with quadrupole orbitrap high-resolution mass spectrometry for differential metabolite analysis of Pinelliae Rhizoma and its adulterants","volume":"29","author":"Wang","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.dmd.2026.100366_bib38","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1021\/acs.jafc.2c08372","article-title":"Comprehensive metabolite profiling of two edible Garcinia species based on UPLC-ESI-QTOF-MS(E) coupled with bioactivity assays","volume":"71","author":"Lin","year":"2023","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.dmd.2026.100366_bib39","series-title":"13'-Carboxy-gamma-tocopherol (HMDB0012557)","year":"2022"},{"key":"10.1016\/j.dmd.2026.100366_bib40","doi-asserted-by":"crossref","first-page":"25290","DOI":"10.1074\/jbc.M201466200","article-title":"Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status","volume":"277","author":"Sontag","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.dmd.2026.100366_bib41","series-title":"6-Deoxodolichosterone (HMDB0034332)","year":"2022"},{"key":"10.1016\/j.dmd.2026.100366_bib42","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1021\/jm049340b","article-title":"Calcitriol derivatives with two different side chains at C-20. II. Diastereoselective syntheses of the metabolically produced 24(R)-hydroxygemini","volume":"47","author":"Maehr","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.dmd.2026.100366_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1011033","article-title":"Cross-ancestry analyses identify new genetic loci associated with 25-hydroxyvitamin D","volume":"19","author":"Wang","year":"2023","journal-title":"PLoS Genet"},{"key":"10.1016\/j.dmd.2026.100366_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/09674845.2020.1785692","article-title":"Association between SLCO1B1 polymorphism distribution frequency and blood lipid level in Chinese adults","volume":"78","author":"Mo","year":"2021","journal-title":"Br J Biomed Sci"},{"key":"10.1016\/j.dmd.2026.100366_bib45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11095-019-2593-8","article-title":"Recovery of OATP1B activity after living kidney transplantation in patients with end-stage renal disease","volume":"36","author":"Suzuki","year":"2019","journal-title":"Pharm Res"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626006355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626006355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:16:49Z","timestamp":1790331409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955626006355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0090955626006355"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100366","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel plasma biomarkers for OATP1B1 activity using nontargeted metabolomics","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100366"}}